• Tidak ada hasil yang ditemukan

Siloam Hospitals | Investor Relations - Company Presentation - Rumah Sakit Siloam Hospitals

N/A
N/A
Protected

Academic year: 2017

Membagikan "Siloam Hospitals | Investor Relations - Company Presentation - Rumah Sakit Siloam Hospitals"

Copied!
52
0
0

Teks penuh

(1)

Provider of The Year

Frost and Sullivan

(2)

2

Disclaimer

This presentation has been prepared by PT Siloam International Hospitals, Tbk (SILO ) and is circulated for the purpose of general

information only. It is not intended for any specific person or purpose and does not constitute a recommendation regarding the securities of SILO. No warranty ( expressed or implied ) is made to the accuracy or completeness of the information. All opinions and estimations included in this report constitute our judgment as of this date and are subject to change without prior notice. SILO disclaims any

responsibility or liability whatsoever arising which may be brought against or suffered by any person as a result of reliance upon the whole or any part of the contents of this presentation and neither SILO nor any of its affiliated companies and their respective employees and agents accept liability for any errors, omission, negligent or otherwise, in this presentation and any inaccuracy herein or omission here from which might otherwise arise.

Forward –Looking Statements

The information communicated in this presentation contains certain statements that are or may be forward looking. These statements

t pi all o tai ords su h as ill , e pe ts a d a ti ipates a d ords of si ilar i port. B their ature, for ard looking statements involve a number of risks and uncertainties that could cause actual events or results to differ materially from those described in this presentation. Factors that could cause actual results to differ include, but are not limited to, economic, social, and political conditions in Indonesia ; the state of the property industry in Indonesia; prevailing market conditions; increases in regulatory burdens in Indonesia, including environmental regulation and compliance cost; fluctuations in foreign currency exchange rates; interest rate trends, cost of capital and capital availability; the anticipated demand and selling prices for SILO developments and related capital expenditures and investments; the cost of construction; availability of real estate property; competition from other companies and venues; shifts in customer demands; changes in operation expenses, including employee wages, benefits, and training, governmental and public policy

ha ges; “ILO’s a ilit to e a d re ai o petiti e; “ILO’s fi a ial o ditio , usi ess strateg as ell as the pla s a d objectives of

“ILO’s a age e t for future operatio s; ge eratio of future re ei a les; a d e iro e tal o plia e a d re ediatio . “hould one or more of these uncertainties or risks, among others, materialize, actual results may vary materially from those estimated, anticipated or projected. Specifically, but without limitation, capital costs could increase, projects could be delayed and anticipated improvements in production, capacity or performance might not be fully realized. Although SILO believes that the expectations of its management as reflected by such forward –looking statements are reasonable based on information currently available to us, no assurances can be given that such expectations will prove to have been correct. You should not unduly rely on such statements. In any event, these statements speak only as of the date hereof, and SILO undertakes no obligation to update or revise any of them, whether as a result of new information, future events or otherwise.

(3)

Where We Are In Lippo Karawaci

04

Corporate Structure

05

Highly Experienced & Professional Management

06

The Vision

07

The Journey

08

The Operations

09

The Strategy & Business Model

10

13

Premier Private Hospital Group

14

23

Hospitals Under Development

24

28

Financial Performance

29

36

Operational Performance

37

44

(4)

4

Where We Are In Lippo Karawaci

9M 2016 Results

As of 30 Sept 2016

No . Of Outstanding Shares : 23,077,689,619 Code : LPKR.JK ; LPKR IJ

PT SILOAM INTERNATIONAL HOSPITALS TBK

LIPPO RELATED COMPANIES

25.46%

PT GOWA MAKASSAR TOURISM DEVELOPMENT TBK

PT LIPPO CIKARANG TBK PT BOWSPRIT ASSET

MANAGEMENT

61.8% 54.4% 59.8% 100%

CREDIT SUISSE AGSG TRACCL MPU

5.25%

PUBLIC

69.29 %

As of 30 Sept 2016

(5)

Corporate Structure

As of 30 Sept 2016

No . Of Outstanding Shares : 1,156,100,000 Code : SILO

LIPPO KARAWACI RELATED COMPANIES

61.82%

CVC CAPITAL PARTNERS

15.00%

PUBLIC

(6)

6

Highly Experienced & Professional Management

9M 2016 Results

dr. Niel Nielson Independent Commissioner

Board of Directors

Romeo Lledo President Director, Independent Director

dr. Andry Director

dr. Anang Prayudi Director

Ryanto Tedjomulja* Director dr. Grace Frelita

Director

Atiff Gill* Director

Board of Commissioners

Lee Heok Seng President Commissioner

Theo L. Sambuaga Commissioner

Ir. Jonathan L. Parapak Independent Commissioner Farid Harianto

Independent Commissioner

Budi Legowo Director Jenny Kuistono

Commissioner

Caroline Riady* Vice President

Director

Norita Alex Director

Andy Purwohardono*

Commissioner

John Pitsonis* Commissioner

(7)

The Vision

Affordable and Accessible Healthcare

to all socio economic segments

By 2019..

Beds

over 10,000

Patients per annum

over 15 million

Hospitals

over 50 hospitals

over 25 cities

Reach

Scale

International

Quality

(8)

8

The Journey

9M 2016 Results

1996

2006: Learning Phase

2007

2010: Consolidation Phase

2011 to Date: Expansion Phase

1996

SH Lippo Village

2002

2011

2012

2013

2014

2016

SH Lippo Cikarang

SH Surabaya

SH Kebon Jeruk

SH Balikpapan

SH Jambi SH MRCCC

RSUS

SH Manado

SH Makassar

SH Palembang

SH Cinere

SH Bali

SH TB Simatupang

BIMC Kuta

BIMC Nusa Dua

SH Medan

Asri

SHLV

– I do esia’s First Hospital to e

Accredited and Re-accredited by JCI

(2007, 2010 and 2014)

2013

The Company

successfully completed IPO

BIMC Nusa Dua

– I do esia’s First

Hospital to be Accredited by ACHS

Australia (2014)

SH Kupang SH Purwakarta

SH Buton SH Labuan

Bajo

(9)

The Operations

Unrivalled network across Indonesia

JCI

Sumatra Population : 50.6 mio

Kalimantan Population : 13.8 mio

Java Population : 136.6 mio

Sulawesi Population : 17.4 mio

Papua Population : 3.6 mio

Bali Population : 3.9 mio

Nusa Tenggara Population : 9.2 mio

Maluku Population : 2.6 mio

Jakarta Population : 10 mio

Greater Jakarta Population : 28 mio

ACHSI

Operational Hospitals (23)

(10)

The Strategy & Business Model

4 Pillar Foundation

11

Clinical Service Delivery

12

(11)

4 Pillar Foundation

Siloa Hospitals’ four pillar fou datio has ee ke to the su ess of our e isti g hospitals a d ill ser e

as the asis for repli ati g this su ess at our e pa sio hospitals…

1 Emergency

Excellence in Emergency Services

1-500-911

2 Technology

3 Telemedicine

4 Doctors

State-of-the-Art Medical Equipment and Systems

Digital Telemedicine Hu a d “poke

Siloam Doctor Partnership and Development Program

(12)

12

Clinical Service Delivery

9M 2016 Results

Primary clinics for corporate clients

Public-Private-Partnership (PPP) model - Siloam Puskesmas (Public Health Clinic)

RSUS –First general hospital using public sector model

Additional demand from patients under governmental insurance and social schemes

Gate ay to I do esia’s U i ersal Health are Co erage a d Go er e t

Health Insurance Programs

• Specialist access for primary healthcare demand

• Public-Private-Partnership

• High standard and accessible medical care through focus on clinical governance and affordable price points

• Access to Centres of Excellence through hub and spoke system and Tele-medicine

3

2

1

“iloa ’s

Integrated Healthcare Delivery Model

Primary Secondary Tertiary

Research and EducationIntegrated platform with UPHMS and other partnerships

Medical students training at RSUS, SHLV, and SHKJ

Integrated Centers of Excellence: Neuroscience, Cardiology, Cancer, Orthopedic, Urology, Fertility

Hub and Spoke strategy and extensive coverage of specialized services via Digital Tele-Medicine

Pio eeri g i est e ts i I do esia’s health are se tor

Comprehensive Cancer Centre opened in 2011

I do esia’s first Ga a K ife i stalled i 2012

Best in class and highly accessible healthcare services platform through:

Rapid expansion of hospital network across Indonesia

Attracting and retaining the best doctors with strong focus on

do tors’ elfare “DPDP

Equip hospitals with State-of-the-Art facilities such as 128 slice CT Scan and 1.5T MRI

One-stop continuum of care at primary, secondary, tertiary and quaternary levels

(13)

UPH Medical Sciences (UPHMS)

Centre of Excellence and Global Reputation

Alignment –across teaching and service delivery

Affiliate with agencies such as ACORN/NUS/SGH/UOM

Leading edge research

Best practice Models

Remote Access Diagnosis (RAD) and Remote Access Clinical Management (RACM)

Telemedicine

Centres of Clinical Excellence/ Accreditation

Teaching Hospital paradigm

Future workforce

Systems based curriculum converged with PBL

Best practice replication

Clinical placement

Foundation for Innovation

Overseas training –

Singapore/Australia/USA/China

Bringing Together Clinical, Research & Education

·

Education Research

(14)

Premier Private Hospital Group

Mature Hospitals

15

Developing Hospitals

16

17

Distinct Market Segment Hospitals

18

New Hospitals

19

Siloam Clinic

20

Completed Hospital In Yogyakarta

21

Completed Hospital In Bogor

22

(15)

308 Bed Capacity 274 Operational Beds 238 GP and Specialists 391 Nurses

Centre of Excellence : Cardiology, Neuroscience, Orthopedics & Emergency

Mature Hospitals

79.61% Ownership

EAST KALIMANTAN

232 Bed Capacity 165 Operational Bed 113 GP and Specialists 162 Nurses

Centre of Excellence : Orthopedics & Emergency SILOAM HOSPITALS BALIKPAPAN

TANGERANG (West of Jakarta)

SILOAM HOSPITALS LIPPO VILLAGE

JCIA

WEST JAKARTA

SILOAM HOSPITALS KEBON JERUK

285 Bed Capacity 215 Operational Beds 208 GP and Specialists 326 Nurses

Centre of Excellence : Urology, Orthopaedic, Cardiology & Emergency

EAST JAVA

SILOAM HOSPITALS SURABAYA

162 Bed Capacity 160 Operational Beds 156 GP and Specialists 247 Nurses

Centre of Excellence : Fertility Treatment, Cardiology & Emergency

JCIA

WEST JAVA

SILOAM HOSPITALS PURWAKARTA

202 Bed Capacity 190 Operational Beds

56 GP and Specialists 180 Nurses

(16)

16

Developing Hospitals

9M 2016 Results

BEKASI (East of Jakarta)

SILOAM HOSPITALS CIKARANG

114 Bed Capacity 108 Operational Beds

93 GP and Specialists 162 Nurses

Centre of Excellence : Occupational Health & Emergency

SOUTH JAKARTA

MRCCC SILOAM SEMANGGI

334 Bed Capacity 155 Operational Beds 173 GP and Specialists 293 Nurses

Centre of Excellence : Cancer, Liver & Emergency

79.84% Ownership

EAST SUMATERA

SILOAM HOSPITALS JAMBI

100 Bed Capacity 90 Operational Beds 66 GP and Specialists 125 Nurses

Centre of Excellence : Emergency

83.0% Ownership

TANGERANG (West of Jakarta)

SILOAM GENERAL HOSPITAL (RSUS)

640 Bed Capacity 300 Operational Beds

52 GP and Specialists 228 Nurses

Centre of Excellence : Emergency

NORTH SULAWESI

SILOAM HOSPITALS MANADO

238 Bed Capacity 177 Operational Beds 108 GP and Specialists 198 Nurses

Centre of Excellence : Emergency

SOUTH SULAWESI

SILOAM HOSPITALS MAKASSAR

362 Bed Capacity 215 Operational Beds 123 GP and Specialists 239 Nurses

(17)

Developing Hospitals

SOUTH SUMATERA

SILOAM HOSPITALS PALEMBANG

357 Bed Capacity 150 Operational Beds 136 GP and Specialists 171 Nurses

Centre of Excellence : Gastroenterology & Emergency

70.00% Ownership

DEPOK (South of Jakarta)

SILOAM HOSPITALS CINERE

50 Bed Capacity 37 Operational Beds 18 GP and Specialists 43 Nurses

Centre of Excellence: Cardiology

80.0% Ownership

SOUTH JAKARTA

SILOAM HOSPITALS TB SIMATUPANG

269 Bed Capacity 100 Operational Beds 155 GP and Specialists 131 Nurses

Centre of Excellence : Cardiology, Oncology, Neuroscience & Emergency

EAST NUSA TENGGARA

SILOAM HOSPITALS KUPANG

416 Bed Capacity 110 Operational Beds

56 GP and Specialists 151 Nurses

Centre of Excellence : Emergency

NORTH SUMATERA

SILOAM HOSPITALS MEDAN

356 Bed Capacity 75 Operational Beds 103 GP and Specialists

82 Nurses

(18)

18

BALI

BIMC KUTA

19 Bed Capacity 18 Operational Beds 51 GP and Specialists 64 Nurses

Centre of Excellence : Treatment for tourists & Emergency

BALI

BIMC NUSA DUA

39 Bed Capacity 24 Operational Beds 57 GP and Specialists 65 Nurses

Centre of Excellence : Cosmetic Surgery & Emergency

Distinct Market Segment Hospitals

9M 2016 Results

SOUTH JAKARTA

SILOAM HOSPITALS ASRI

40 Bed Capacity 40 Operational Beds 100 GP and Specialists

79 Nurses

Centre of Excellence : Urology

BALI

SILOAM HOSPITALS BALI

281 Bed Capacity 110 Operational Beds 122 GP and Specialists 195 Nurses

(19)

New Hospitals

EAST NUSA TENGGARA

SILOAM HOSPITALS LABUAN BAJO

124 Bed Capacity 60 Operational Beds 20 GP and Specialists 64 Nurses

Centre of Excellence : Emergency

SOUTHEAST SULAWESI

SILOAM HOSPITALS BUTON

140 Bed Capacity 30 Operational Beds 32 GP and Specialists 69 Nurses

Centre of Excellence : Emergency

EAST KALIMANTAN

SILOAM HOSPITALS SAMARINDA

34 Bed Capacity 10 Operational Beds 34 GP and Specialists 18 Nurses

(20)

20

Siloam Clinic

9M 2016 Results

CYBER PARK KARAWACI

MERTANADI BALI

FAÇADE RECEPTION GP’s CON“ULTATION ROOM

(21)

Completed Hospital In Yogyakarta

FAÇADE MAIN LOBBY

(22)

22

Completed Hospital In Bogor

9M 2016 Results

FAÇADE MAIN LOBBY

(23)

Completed Hospital In Bekasi Blu Plaza

FAÇADE FRONT OFFICE

OUT PATIENT DEPARTMENT

(24)

Hospitals Under Development

Licensing Requirement

25

(25)

Licensing Requirement

Licensing Process

In order to be able to fully commission a new hospital, we have to go through a licensing process involving local governments and provincial health departments. This process involves more than 40 licenses and can be summarized into 6 most critical licenses.

Environmental License (AMDAL)

Building Permit (IMB)

Nuisance Permit (HO)

Hospital Building Permit

(IMRS)

Certificate of Proper Building

Function (SLF)

Operational License (IO)

Status of Major Projects for 2016 & 2017

Hospital AMDAL IMB HO IMRS SLF IO

Yogyakarta

Bekasi Blu Plaza

Bogor

Bangka

Lubuk Linggau

Jember

Sorong

Semarang Hoo

Bekasi Grand Mall

Banjarmasin

(26)

26

For Completion In 2017

9M 2016 Results

BANJARMASIN

BATU LIPPO MALL

BEKASI GRAND MALL

KALIMALANG

LIPPO KUNINGAN

MANADO KAIRAGI

NINE RESIDENCE

PALANGKARAYA

(27)

For Completion In 2017

JEMBER

June 2016 Current

BANGKA BELITUNG

June 2016 Current

LUBUK LINGGAU

(28)

28

For Completion In 2017

9M 2016 Results

SORONG

(29)

Strong Financial Performance

30

Revenue & EBITDA Details

31

Balance Sheets

32

Steady Ramp-up Model

33

Hospitals Ramp-Up

34

35

(30)

30

Strong Financial Performance

9M 2016 Results

Siloam is the clear leader and fastest growing private hospital group in Indonesia serving all segments of the population 881

FY 2011 FY 2012 FY 2013 FY 2014 FY 2015 9M 2016

155

FY 2011 FY 2012 FY 2013 FY 2014 FY 2015 9M 2016

+42%

GOR refers to revenues relating to medical support services, professional fees and consultation fees, drugs and medical supplies, room service, administration, operating theatre, delivery rooms, registration fees and other services. NOR is calculated by deducting service costs (doctor consultation and professional fees) from GOR.

(31)

Revenue & EBITDA Details

Notes:

(i) Represents rental expenses for the land and buildings, Siloam is leasing from FREIT, PT Lippo Karawaci Tbk and other parties. PT Lippo Karawaci started charging rent for the land and buildings of 9 hospitals on May 1,2013.

(ii) EBITDA refers to income before depreciation, provisions for post-employment benefits, allowance for impairment in value, corporate income taxes and other expense and/or income (consisting primarily of financing income and others-net).

In IDR Bn

9M

∆%

2015 2016

GOR 3,013 3,824 27%

Service Cost 795 1,060 33%

NOR 2,218 2,764 25%

Material Cost 886 1,094 24%

Gross Margin 1,333 1,670 25%

Operating Expenses 832 1,074 29%

EBITDAR 501 596 19%

% to GOR 16.6% 15.6%

% to NOR 22.6% 21.6%

Rental(i) 69 96 38%

EBITDA(ii) 431 500 16%

% to GOR 14.3% 13.1%

% to NOR 19.4% 18.1%

NPAT 68 95 40%

% to GOR 2.2% 2.5%

(32)

32

Balance Sheets

9M 2016 Results

In IDR Bn

2015

9M 2016

∆%

Assets

Cash & Equivalent 160 106 -34%

Other Current Assets 796 1,040 31%

Property and Equipment 1,553 1,620 4%

Other Non-Current Assets 477 540 13%

Total Assets

2,986

3,306

11%

Liabilities & Equity

Debt 384 449 17%

Liabilities 1,246 1,472 18%

Shareholders' Equity 1,740 1,834 5%

Total Liabilities & Equity

2,986

3,306

11%

Gearing Ratio 0.22 0.24 11%

(33)

46% 42% 53% 49%

42% 45% 28%

34%

-4% 13% 12%

20%

21%

9M 2015 9M 2016 9M 2015 9M 2016

Mature Developing Distinct New

Steady Ramp-up Model

EBITDA Margin

Note:

EBITDA refers to income before depreciation, provisions for post-employment benefits, allowance for impairment in value, corporate income taxes and other expense and/or income (consisting primarily of financing income and others-net).

Revenue EBITDA

27% 28%

15%

18% 35%

37%

0%

9M 2015 9M 2016

Mature Developing Distinct New

-257%

Contribution

Increasing contribution from developing hospitals

(34)

34

102

227

Revenue FY 2013 FY 2015

13.5%

24.8%

EBITDA Margin FY 2013 FY 2015

34.5%

62.7%

Occupancy Rate FY 2013 FY 2015

179

OPD Visits FY 2013 FY 2015

4,893

11,628

IPD Admissions FY 2013 FY 2015

Hospitals Ramp-Up

9M 2016 Results

Manado (Operational in 2012)

Makassar (Operational in 2012)

94

207

Revenue FY 2013 FY 2015

-0.5%

22.2%

EBITDA Margin FY 2013 FY 2015

40.3%

71.2%

Occupancy Rate FY 2013 FY 2015

177

OPD Visits FY 2013 FY 2015

5,299

8,377

IPD Admissions FY 2013 FY 2015 % to NOR

(35)

113

162

Revenue FY 2014 FY 2015

16.2%

21.8%

EBITDA Margin FY 2014 FY 2015

42.9%

47.0%

Occupancy Rate FY 2014 FY 2015

80

OPD Visits FY 2014 FY 2015

2,863

3,475

IPD Admissions FY 2014 FY 2015

Hospitals Ramp-Up

Palembang (Operational in 2012)

TB (Operational in 2013)

92

158

Revenue FY 2013 FY 2015

9.6 %

21.1%

EBITDA Margin FY 2013 FY 2015

43.8%

69.2%

Occupancy Rate FY 2013 FY 2015

135

OPD Visits FY 2013 FY 2015

4,916

7,831

IPD Admissions FY 2013 FY 2015 % to NOR

(36)

36

Comparable Margin with Peers

9M 2016 Results

SILO EBITDA Margin

27.0%

15.0%

34.7%

28.0%

18.5%

37.5%

Mature Developing Distinct New

9M 2015 9M 2016

-256.8%

SILO EBITDAR Margin

Siloam Mature and Distinct Hospitals EBITDAR Margin are comparable to the Peers EBITDA Margin 30.0%

18.4%

36.9%

31.5%

22.2%

39.8%

Mature Developing Distinct New

9M 2015 9M 2016

-247.6%

Peers EBITDA Margin

Note:

EBITDAR refers to income before depreciation, provisions for post-employment benefits, allowance for impairment in value, corporate income taxes, other expense and/or income (consisting primarily of financing income and others-net) and rental. EBITDA refers to income before depreciation, provisions for post-employment benefits, allowance for impairment in value, corporate income taxes and other expense and/or income (consisting primarily of financing income and others-net).

21.6%

23.7%

30.0%

37.8%

Hospital A Hospital B Hospital C Hospital D

(37)

Medical Equipment Utilization

38

Outpatient Visits

39

Emergency Visits

40

In-patient Admissions

41

Bed Occupancy Rate

42

Average Revenue Per Patient

43

(38)

38

Mature Developing Distinct New Consolidated

9M 2015 9M 2016

Medical Equipment Utilization

9M 2016 Results

29.2%

Mature Developing Distinct New Consolidated

9M 2015 9M 2016

CT-Scan

(39)

567,887

482,912

101,171

-1,151,970

615,407 627,403

132,714

10,430

1,385,954

Mature Developing Distinct New Consolidated

2015 2016

180,487 164,039

34,897

-379,423

191,247 210,777

44,232

6,171

452,427

Mature Developing Distinct New Consolidated

2015 2016

Nine Months Ended September 30

3

rd

Quarter

Outpatient Visits

196,889 152,962

33,209

-383,060

215,036 207,497

42,740

1,025

466,298

Mature Developing Distinct New Consolidated

2015 2016

190,511 165,911

33,065

-389,487

209,124 209,129

45,742

3,171

467,166

Mature Developing Distinct New Consolidated

2015 2016

2

nd

Quarter

1

st

Quarter

(40)

40

68,143 67,072

18,692

-153,907

77,826 80,768

22,371

2,096

183,061

Mature Developing Distinct New Consolidated

2015 2016

21,474 21,728

Mature Developing Distinct New Consolidated

2015 2016

Nine Months Ended September 30

3

rd

Quarter

Emergency Visits

9M 2016 Results

24,440 23,473

Mature Developing Distinct New Consolidated

2015 2016

22,229 21,871

Mature Developing Distinct New Consolidated

2015 2016

2

nd

Quarter

1

st

Quarter

(41)

46,793 51,968

8,261

-107,022

51,355

64,872

9,921

1,567

127,715

Mature Developing Distinct New Consolidated

2015 2016

14,745 17,098

Mature Developing Distinct New Consolidated

2015 2016

Nine Months Ended September 30

3

rd

Quarter

In-patient Admissions

16,144 17,841

Mature Developing Distinct New Consolidated

2015 2016

15,904 17,029

Mature Developing Distinct New Consolidated

2015 2016

2

nd

Quarter

1

st

Quarter

(42)

42

Mature Developing Distinct New Consolidated

2015 2016

62%

Mature Developing Distinct New Consolidated

2015 2016

Nine Months Ended September 30

3

rd

Quarter

Bed Occupancy Rate

9M 2016 Results

69%

Mature Developing Distinct New Consolidated

2015 2016

67%

Mature Developing Distinct New Consolidated

2015 2016

2

nd

Quarter

(43)

0.8 0.8

Mature Developing Distinct New Consolidated

FY 2013 FY 2014 FY 2015 9M 2016

Average Revenue Per Patient

19.7

Mature Developing Distinct New Consolidated

FY 2013 FY 2014 FY 2015 9M 2016

In-patient Average Revenue Per Patient

Blended Out Patient Average Revenue Per Patient

IDR Mn

(44)

44

151 189

304

445 421 735

960

1,209

1,503

1,699

FY 2011 FY 2012 FY 2013 FY 2014 FY 2015

GP Specialist

Manpower Availability

9M 2016 Results

Nurses

Note:

EBITDA refers to income before depreciation, provisions for post-employment benefits, allowance for impairment in value, corporate income taxes and other expense and/or income (consisting primarily of financing income and others-net).

1,576

1,948

2,628

3,244

3,564

FY 2011 FY 2012 FY 2013 FY 2014 FY 2015

Nurses

Doctors

Siloa ’s rete tio of Doctors and Nurses is strong

(45)

Comparison Health Statistics

46

(46)

46

Comparison Health Statistics

9M 2016 Results

Source : World Bank, WHO 2016

Indonesia Vietnam Malaysia Singapore South Korea India China Australia USA UK

Hospital beds per 10,000 pops 9 20 19 20 103 7 38 39 29 29

Physician per10,000 pops 2 12 12 20 21 7 15 33 25 28

Health Profesionals per 10,000

pops 16 24 45 77 72 24 32 139 123 116

Per capita total expenditure on

healthcare (USD) 293 308 938 3.578 2.398 215 646 4.191 9.146 3.311 South Korea USA UK Australia

Physicians per 10,000 pops

3.1 South Korea UK Australia USA

(47)

Hospitals in Indonesia

No OWNER 31 Dec 10 31 Dec 11 31 Dec 12 31 Dec 13 31 Dec 14 31 Dec 15 30 Sep 16

1 MOH 31 32 32 33 34 36 33

2 PROVINCE GOVERNMENT 85 85 89 96 98 113 119

3 MUNICIPAL GOVERNMENT 63 86 88 92 93 98 97

4 DISTRICT GOVERNMENT 403 411 444 455 463 469 477

5 ARMY / POLICE 131 134 155 159 170 170 167

6 OTHER MINISTRIES /

PUBLIC COMPANIES

79 80 79 79 79 79 75

7 PRIVATE 840 893 1,179 1,314 1,472 1,525 1,612

TOTAL 1,632 1,721 2,066 2,228 2,409 2,490 2,580

(48)
(49)
(50)
(51)

Siloam is the leading private hospital network with 23 hospitals in 17 cities across Indonesia.

Siloam Hospitals Group is Indonesia’s most progressive and innovative healthcare provider that has set the benchmark for quality healthcare

(52)

52

Online Appointment : www.siloamhospitals.com

Appointment and General Information, contact : 1 –500 –181

Referensi

Dokumen terkait

Két egyenes merőleges egymásra pontosan akkor, ha az irányvektoraik merőlegesek egymásra, azaz az irányvektoraik

demikian dapat dilihat bahwa thitung > ttabel maka berdasarkan kriteria uji H0 ditolak dan Ha diterima, artinya bahwa ada hubungan yang signifikan antara pola

Kepada seluruh peserta Pengadaan Jasa Konsultansi yang merasa keberatan atas ditetapkannya pemenang tersebut di atas, dapat mengajukan sanggahan kepada Pokja Jasa

Demikian Penetapan Peringkat Teknis ini untuk menjadi maklum. Fakfak, 11

Demikian Pemberitahuan/Pengumuman Peringkat Teknis ini untuk menjadi maklum. Fakfak, 11 April 2015

Jenis penelitian ini adalah penelitian non-ekseperimental berupa deskriptif kuantitatif. Variabel bebas dalam penelitian ini adalah kompetensi guru penjasorkes dan variabel

[r]

Demikian kami sampaikan, atas perhatiaannya kami ucapkan